These results together demonstrated a pivotal role of BAP1 in its oncogenic function in NB and uncovered a novel regulator for MYCN which is highly correlated with drugs resistance in MYCN -amplified NB cells. The gene discussed is BAP1; the disease is neuroblastoma.